Close

Explore AI

Explore GPTs

Explore AI News

Explore AI Videos

Explore AI for Jobs

Latest Baylor College of Medicine AI Videos

Find the latest for Baylor College of Medicine company videos

Follow
... 5:13
Cortex AI -Paradigm Shift Innovation in Medical Education on DAMS eMedicoz App

DAMS eMedicoz : NEET PG, MBBS, FMGE, USMLE Prep

1+ months ago 6K views

Dams is introducing a new era of education powered by artificial intelligence through its Cortex AI system, which will enhance learning for medical and nursing students by summarizing lectures, predicting test performance, and providing personalized support. This transformation integrates AI to help students identify weaknesses and improve their knowledge, offering advantages in competitive exams. Along with AI features, Dams is launching a personalized one-on-one program, allowing students to resolve doubts and receive tailored tutoring. The goal is to create an interactive, two-way learning experience that personalizes education for each student's needs using technology.
eMedicoz Machine Learning Education
... 14:23
𝗨𝗦𝗔 𝟮𝟬𝟮𝟱 👉 AI Made From HUMAN BLOOD Miry Clay Cleaved To Iron - #2025 #RFB

Richie From Boston - FanPage

1+ months ago 3K views

The CL1 computer represents a breakthrough in AI, merging biological neurons from human stem cells with silicon technology to create a new form of synthetic biological intelligence. This innovative system learns rapidly and adapts more effectively than traditional silicon-based AI while consuming less energy. The technology could transform drug testing and personalized medicine by utilizing patient-derived neurons. However, the development raises ethical concerns regarding its source of biological material and its ramifications for society and human health.
03:53 - 04:05

Prediction of the CL1's impact on drug discovery and overall medical advancements.

Melbourne start-up AI hardware Research & Innovations
... 11:5
Huge News: The First AI that Runs on Human Brain Cells is Finally Here!

AI Uncovered

1+ months ago 17K views

The CL1 biocomputer, developed by Cortical Labs, represents a significant advancement in artificial intelligence by integrating human brain cells with silicon hardware. Unlike traditional AI, the CL1 can learn and adapt more rapidly while consuming less energy. This biological computer is designed to simulate heuristic processing similar to a real brain, and its potential applications span medical research, substance discovery, and robotics. The CL1 aims to reduce the need for complex hardware and software, making synthetic biological intelligence more accessible to researchers and innovators. This groundbreaking technology will be available in late 2025.
03:03 - 03:06

CL1 technology could transform substance discovery and clinical testing.

AI hardware Research & Innovations
... 12:13
End Times: This New AI Tech Fulfills Bible Prophecy

End Times Productions

1+ months ago 33K views

The CL1 computer, created by Cortical Labs in Australia, utilizes living human brain cells embedded in a silicon chip to process information, marking a significant step in biological computing. Priced at $35,000, it requires life support systems to maintain the neurons and promises advancements in AI and machine learning. The implications of such technology raise ethical concerns, suggesting a fusion of technology and biology, and prompting discussions regarding potential control by malevolent entities or unintended consequences. This innovation may redefine the future of AI applications, including personalized medicine and advanced robotics.
04:12 - 04:30

Biological computers could improve AI efficiency, especially in unpredictable environments.

AI hardware Research & Innovations
... 32:41
Military Medicine 2.0: AI, Telemedicine & Mental Health || Brass Talks

Bharat Shakti

1+ months ago 4K views

The Army Medical Corps operates under the motto 'surve santu Naya,' advocating for freedom from disease and suffering. Emphasizing wellness, the corps integrates modern technology, primarily AI, to enhance medical care for armed forces personnel, including telemedicine and digital health innovations. The Director-General discusses the importance of ensuring mental health support, facilitating last-mile medical services, and addressing climate-related health challenges. Through proactive training and improved facilities, the corps aims to provide robust medical support in combat and remote environments, reflecting a commitment to the well-being of soldiers and their families.
03:46 - 04:11

Telemedicine enables remote medical assistance, improving soldier care.

Natural Language Processing (NLP) Healthcare
... 9:26
The Role of AI in Personalized Medicine Tailoring Treatments for Every Patient

The Transforming Treatment Institute

1+ months ago 3K views

Personalized medicine, driven by advanced AI technologies, transforms healthcare by tailoring treatments to individual genetic profiles and environmental factors. This approach moves beyond one-size-fits-all practices, enabling predictive analytics for conditions such as heart disease and cancer. AI's power in genomics allows for faster and cheaper sequencing of DNA, assisting in early diagnosis and customized treatment plans. Future advancements promise a shift from reactive to proactive healthcare, empowering patients and doctors alike through continuous data monitoring and tailored interventions, ultimately enhancing survival rates and improving overall health outcomes.
02:38 - 02:42

Genomic profiling with AI identifies mutations for targeted cancer therapies.

Machine Learning Healthcare
... 4:19
Revolutionizing Healthcare: Dubai’s AI & Pharma Innovation Hub

Indiatimes

1+ months ago 62K views

Transforming healthcare requires more than just advanced technology; it calls for a relentless pursuit of better outcomes for patients and society. Breakthroughs driven by artificial intelligence and the Internet of Things currently reshape healthcare delivery, anticipating conditions before symptoms arise and relaying critical patient data in real-time. Tools like the EJ Ada AI system personalize treatments and improve preventive care. Collaborative hubs foster innovation, enabling solutions that make healthcare more accessible and efficient, while global partnerships boost advancements in personalized medicine and vaccine development. The movement to enhance healthcare is ongoing, and active participation in these innovations is essential.
01:55 - 02:10

Dubai encourages innovation, attracting global entrepreneurs with supportive infrastructure.

Robotics Healthcare
... 8:29
IPA Stock - AI Company to Watch (Update)

Blaze Capital

1+ months ago 10K views

Immuno Precise Antibodies (IPA), listed on NASDAQ as IPA, aims to revolutionize healthcare and drug discovery through its patented Lens AI technology. With over 90% of clinical drug developments failing, IPA addresses this challenge by accelerating drug discovery and integrating artificial intelligence with biological data. Their HFT patterns program introduces unique signature sequences, enabling the harmonization of complex biological data. The potential market for AI in drug discovery is projected to be worth $24.6 billion by 2029. The company is making strides in developing precision-targeted treatments, particularly for cancer, enhancing drug efficacy with fewer side effects.
04:01 - 04:06

In silico antibodies targeting tumor proteins show AI's efficacy in drug development.

Immunoprecise Antibodies Ltd Finance
... 8:29
IPA Stock - AI Company to Watch (Update)

Blaze Capital

1+ months ago 10K views

Immuno Precise Antibodies (IPA), listed on NASDAQ as IPA, aims to revolutionize healthcare and drug discovery through its patented Lens AI technology. With over 90% of clinical drug developments failing, IPA addresses this challenge by accelerating drug discovery and integrating artificial intelligence with biological data. Their HFT patterns program introduces unique signature sequences, enabling the harmonization of complex biological data. The potential market for AI in drug discovery is projected to be worth $24.6 billion by 2029. The company is making strides in developing precision-targeted treatments, particularly for cancer, enhancing drug efficacy with fewer side effects.
04:01 - 04:06

In silico antibodies targeting tumor proteins show AI's efficacy in drug development.

Immunoprecise Antibodies Ltd Finance